review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0039-6257(99)00010-7 |
P698 | PubMed publication ID | 10416755 |
P2093 | author name string | Neufeld AH | |
P2860 | cites work | The L-arginine-nitric oxide pathway | Q24304874 |
Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform | Q30990194 | ||
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis | Q33642743 | ||
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase | Q34583665 | ||
The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway | Q35335352 | ||
Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury | Q35824606 | ||
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine | Q36817052 | ||
Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli | Q36820345 | ||
Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma | Q36867060 | ||
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures | Q37552767 | ||
Nitric oxide: a physiologic messenger molecule | Q40394921 | ||
Nitric oxide signaling in the central nervous system | Q40401511 | ||
Redox signaling: nitrosylation and related target interactions of nitric oxide | Q40630842 | ||
Gases as biological messengers: nitric oxide and carbon monoxide in the brain | Q40701647 | ||
The optic nerve head in glaucomatous optic neuropathy | Q41390007 | ||
Regulation of endothelial nitric-oxide synthase during hypoxia. | Q42518861 | ||
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds | Q48233568 | ||
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures | Q48281625 | ||
Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion | Q48291448 | ||
Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats | Q48617782 | ||
Widespread peroxynitrite-mediated damage in Alzheimer's disease | Q48728343 | ||
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism | Q49077300 | ||
Nitric oxide synthase in the human glaucomatous optic nerve head. | Q53971620 | ||
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. | Q67403760 | ||
Distribution of axonal and glial elements in the rhesus optic nerve head studied by electron microscopy | Q67524818 | ||
Evidence of constriction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other mammals | Q70875941 | ||
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma | Q70999763 | ||
Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice | Q71483815 | ||
Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase | Q71647466 | ||
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains | Q71659583 | ||
Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma | Q71722798 | ||
Programmed cell death of retinal ganglion cells during experimental glaucoma | Q71735807 | ||
Inducible nitric oxide synthase in retinal ischemia-reperfusion injury | Q71971578 | ||
Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion | Q72397927 | ||
P921 | main subject | retinal ganglion cell | Q927337 |
P304 | page(s) | S129-35 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | Survey of Ophthalmology | Q7647088 |
P1476 | title | Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma | |
P478 | volume | 43 Suppl 1 |
Q50516135 | 670 nm red light preconditioning supports Müller cell function: evidence from the white light-induced damage model in the rat retina. |
Q48100772 | Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat. |
Q37085063 | Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2. |
Q39936732 | Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo |
Q44580601 | Beta-adrenergic receptor agonists and antagonists counteract LPS-induced neuronal death in retinal cultures by different mechanisms |
Q38770795 | Biomarkers for glaucoma: from the lab to the clinic |
Q25257626 | Brazilian green propolis protects against retinal damage in vitro and in vivo |
Q42588146 | Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma |
Q33477806 | Current concepts in the pathophysiology of glaucoma |
Q43406670 | Decreased total antioxidants in patients with primary open angle glaucoma |
Q35531764 | Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma |
Q79624489 | Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension |
Q40672130 | Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells |
Q44713044 | Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure |
Q35997726 | Diabetes mellitus as a risk factor for glaucomatous optic neuropathy |
Q77840980 | Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray |
Q33790678 | Differential gene expression in glaucoma |
Q35820704 | Effect of nitric oxide compounds on monkey ciliary muscle in vitro |
Q42342948 | Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences |
Q35584834 | Eyeing endothelins: a cellular perspective |
Q52313051 | Frontiers of Complex Disease Mechanisms: Membrane Surface Tension May Link Genotype to Phenotype in Glaucoma. |
Q44186861 | Ganglion cell apoptosis and increased number of NADPH-d-positive neurones in the rodent retina in an experimental model of glaucoma. |
Q36512655 | Genipin Derivatives Protect RGC-5 from Sodium Nitroprusside-Induced Nitrosative Stress |
Q27011820 | Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha |
Q35609009 | Glaucomatous optic neuropathy: when glia misbehave |
Q33311386 | Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model |
Q33282259 | Involvement of ER stress in retinal cell death |
Q42968438 | Involvement of brain-derived neurotrophic factor in time-dependent neurodegeneration in the murine superior colliculus after intravitreal injection of N-methyl-D-aspartate. |
Q36833382 | Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma |
Q40006536 | Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies |
Q36401275 | Mechanosensitivity and the eye: cells coping with the pressure |
Q34019667 | Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2 |
Q43111984 | Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma |
Q61818354 | Mouse model of ocular hypertension with retinal ganglion cell degeneration |
Q35704053 | Neuroprotection in ophthalmology: a review |
Q34373200 | Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress. |
Q43096908 | Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis |
Q40743424 | Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor |
Q48953762 | Nitric oxide potentiates TNF-α-induced neurotoxicity through suppression of NF-κB. |
Q28546739 | Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats |
Q35140846 | Ophthalmic drug discovery |
Q34493838 | Oxidative DNA damage and total antioxidant status in glaucoma patients |
Q48875855 | Oxidative stress and glaucoma: injury in the anterior segment of the eye. |
Q36770323 | Pharmacological neuroprotection for glaucoma |
Q34264120 | Physiological approaches to neuroprotection. boosting of protective autoimmunity |
Q50458445 | Primary open-angle glaucoma and systemic diseases |
Q39051436 | Protective effects of placental growth factor on retinal neuronal cell damage |
Q44239958 | Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina |
Q39707136 | Protective mechanism of agmatine pretreatment on RGC-5 cells injured by oxidative stress |
Q37765626 | REVIEW: An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in mice |
Q34264108 | Relevance of the site of injury of glaucoma to neuroprotective strategies |
Q42914157 | Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice |
Q35174023 | Retinal ganglion cells and neuroprotection for glaucoma |
Q37612344 | Review on Hypothetical Implementing TGF-β Family Members in Glaucoma Therapy |
Q46687157 | Rutin, A Natural Flavonoid Protects PC12 Cells Against Sodium Nitroprusside-Induced Neurotoxicity Through Activating PI3K/Akt/mTOR and ERK1/2 Pathway |
Q34447581 | Serum and antibodies of glaucoma patients lead to changes in the proteome, especially cell regulatory proteins, in retinal cells |
Q28393364 | Short-Term Moderately Elevated Intraocular Pressure Is Associated With Elevated Scotopic Electroretinogram Responses |
Q34599905 | Soluble guanylate cyclases in the retina |
Q35140643 | Stereoselective reduction of 1-o-isopropyloxygenipin enhances its neuroprotective activity in neuronal cells from apoptosis induced by sodium nitroprusside |
Q42913457 | TRPV1 receptors are involved in protein nitration and Müller cell reaction in the acutely axotomized rat retina |
Q34388254 | The immune response in glaucoma: a perspective on the roles of oxidative stress |
Q42008252 | The influence of visible light exposure on cultured RGC-5 cells |
Q33882462 | The optic nerve head in glaucoma: role of astrocytes in tissue remodeling |
Q34342616 | The regulatory role of nitric oxide in apoptosis |
Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
Q38245648 | The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms. |
Q38088355 | Therapeutic potential of Curcuma longa, the golden spice of India, in drug discovery for ophthalmic diseases. |
Q34004263 | Topography of neuron loss in the retinal ganglion cell layer in human glaucoma |
Q34430029 | Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction |
Q39859940 | Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress |
Q90043941 | iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model |
Search more.